Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Antoniou, AC" or (type any "bookEditor journalEditor issueEditor" and editor="Antoniou, AC")

Add to list
- Journal Article
- A1
- open access
Fine-scale mapping at 9p22.2 identifies candidate causal variants that modify ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

E Vigorito, KB Kuchenbaecker, J Beesley, J Adlard, BA Agnarsson, IL Andrulis, BK Arun, L Barjhoux, M Belotti, J Benitez, et al.

(2016) PLOS ONE. 11(7).
Add to list
- Journal Article
- A1
- open access
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

C Zeng, XY Guo, JR Long, KB Kuchenbaecker, A Droit, K Michailidou, M Ghoussaini, S Kar, A Freeman, JL Hopper, et al.

(2016) BREAST CANCER RESEARCH. 18.
Add to list
- Journal Article
- A1
- open access
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

FJ Couch, KB Kuchenbaecker, K Michailidou, GA Mendoza-Fandino, S Nord, J Lilyquist, C Olswold, E Hallberg, S Agata, H Ahsan, et al.

(2016) NATURE COMMUNICATIONS. 7.
Add to list
- Journal Article
- A1
- open access
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

K Lawrenson, S Kar, K McCue, K Kuchenbaeker, K Michailidou, J Tyrer, J Beesley, SJ Ramus, QY Li, MK Delgado, et al.

(2016) NATURE COMMUNICATIONS. 7.
Add to list
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

P Peterlongo, J Chang-Claude, KB Moysich, A Rudolph, RK Schmutzler, J Simard, P Soucy, RA Eeles, DF Easton, U Hamann, et al.

(2015) CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 24(1). p.308-316
Add to list
Identification of six new susceptibility loci for invasive epithelial ovarian cancer

KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, K Lawrenson, L McGuffog, S Healey, JM Lee, et al.

(2015) NATURE GENETICS. 47(2). p.164-171
Add to list
Breast-cancer risk in families with mutations in PALB2

AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, A Lee, D Subramanian, Kim De Leeneer (UGent) , F Fostira, et al.

(2014) NEW ENGLAND JOURNAL OF MEDICINE. 371(6). p.497-506
Add to list
- Journal Article
- A1
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

A Osorio, RL Milne, G Pita, P Peterlongo, T Heikkinen, J Simard, G Chenevix-Trench, AB Spurdle, J Beesley, X Chen, et al.

(2009) BRITISH JOURNAL OF CANCER. 101(12). p.2048-2054
Add to list
- Journal Article
- A1
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

AC Antoniou, OM Sinilnikova, L McGuffog, S Healey, H Nevanlinna, T Heikkinen, J Simard, AB Spurdle, J Beesley, XQ Chen, et al.

(2009) HUMAN MOLECULAR GENETICS. 18(22). p.4442-4456

Academic Bibliography

Fine-scale mapping at 9p22.2 identifies candidate causal variants that modify ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Breast-cancer risk in families with mutations in PALB2

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Contents

Support

Contact